Citi Pharma, a Pakistani pharmaceutical company, has partnered with an Indian company, Murli Krishna Pharma Pvt Ltd (MKPL). Citi Pharma on Tuesday informed the shareholders in a stock filing that it has entered into an agreement with MKPL, a company incorporated and existing under the relevant laws of India. Under the agreement, MKPL will supply Citi Pharma Ltd. with Active Pharmaceutical In